scispace - formally typeset
R

Romano Demicheli

Researcher at University of Milan

Publications -  70
Citations -  2447

Romano Demicheli is an academic researcher from University of Milan. The author has contributed to research in topics: Breast cancer & Cancer. The author has an hindex of 24, co-authored 68 publications receiving 2242 citations.

Papers
More filters
Journal ArticleDOI

The effects of surgery on tumor growth: a century of investigations

TL;DR: The idea that surgical cancer resection has both beneficial and adverse effects upon cancer spread and growth that result from the modulation of tumor dormancy by the resection should be considered a potentially fruitful working hypothesis.
Journal ArticleDOI

Does surgery unfavourably perturb the "natural history" of early breast cancer by accelerating the appearance of distant metastases?

TL;DR: This historical perspective on breast cancer tells us how and why certain therapeutic eras have reached ascendancy and then declined and why a new crisis is upon us now in that trials of early detection have resulted in unexpected disadvantages to certain subgroups and clinical data that suggests the act of surgery might accelerate the appearance of distant metastases.
Journal ArticleDOI

Local recurrences following mastectomy: support for the concept of tumor dormancy

TL;DR: This study provides evidence that the hypothesis of uninterrupted constant growth of locally recurring breast tumors should be rejected, as it implies a statistically significant departure from observed data.
Journal ArticleDOI

Dormancy and surgery-driven escape from dormancy help explain some clinical features of breast cancer.

TL;DR: It is proposed that metastatic breast cancer growth commonly includes periods of temporary dormancy at both the single cell phase and the avascular micrometastasis phase, and surgery to remove the primary tumor often terminates dormancy resulting in accelerated relapses.
Journal ArticleDOI

Hypothesis: Induced angiogenesis after surgery in premenopausal node-positive breast cancer patients is a major underlying reason why adjuvant chemotherapy works particularly well for those patients.

TL;DR: It is suggested that surgical extirpation of primary breast cancer among other effects accelerates relapse for some premenopausal node-positive patients, and short-course cytotoxic chemotherapy after surgery has probably reached its zenith, and other strategies are needed to successfully treat more patients.